Skip to main content

Table 2 hAR inhibitory activities of the Kampo formulations

From: Inhibitory activities of selected Kampo formulations on human aldose reductase

Kampo formulation IC50 a)
μg/mL μUnit/mL
Chotosan 43.6 (±3.1) 5.81
Yokukansan 48.9 (±6.8) 6.52
Keishikajutsubuto 50.2 (±3.5) 6.69
Goshajinkigan 56.7 (±22.3) 7.56
Sokeikakketuto 68.4 (±9.2) 9.12
Shichimotsukokato 69.2 (±11.1) 9.23
Hachimijiogan 71.6 (±44.0) 9.55
Yokukansankachinpihange 83.4 (±10.4) 11.12
epalrestat b) 0.014 (±0.003) 0.098
  1. a)The values are presented as the means (± SD), n = 3.
  2. b)Positive control.